LevelJump Announces 2026 Q1 Financial Results

Sentiment Analysis
LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") , is pleased to announce its financial results for the quarter ended March 31, 2026. Financial and Operational Highlights Revenues were $4.7 million in the first quarter of 2026 compared to $4.58 million in revenues for the first quarter of 2025, a year over year revenue increase of 2.7%. Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA of $624,311 in the first quarter of 2026. 2026 Financial Results for first quarter Revenues of $4.7 million in Q1 2026 with a net loss of $375,923. EBITDA of $194,468 in Q1 2026. Non-IFRS Financial Measures This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity. For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Interim Condensed Consolidated Financial Statements for the quarter ended March 31, 2026, which are available on the Company's website ( www.leveljumphealthcare.com ) and under the Company's profile on SEDAR+ ( www.sedarplus.ca ). About LevelJump Healthcare LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through...
Source: Newsfile Corp
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.